Skip to content

PHARMAMED

Active
Public limited companyfounded 199135 yrs activeDokter Lemoinelaan 11, 1070 Anderlecht, BelgiumKBO/BCE: BE 0444.844.572
Summary

PHARMAMED has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €439,425 and a net result of €186,710. Equity is growing by ~5.8% per year across the filed fiscal years. Its solvency ranks better than 33% of 5046 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability85▲+4
Solvency55=
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity tight (current ratio 1.31 against 1.29 in 2024; short-term debt: 68.7% and cash: 28.4% of total assets), and 69.6% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 35 years 0 40 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
30.4%
Return on assets
12.9%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
56 d early
2024
15 d early
2023
23 d late
2022
25 d late
2020
19 d late
2019
28 d late
2018
29 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 8 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 19 August (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 2 August 1991, PHARMAMED was incorporated.1 Total assets went from EUR 809,309 in 2018 to EUR 1.4 million in 2025 and headcount from 4 to 6.2 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€186,710▲ 46.5%
2024 · €127,432
Working capital
€306,755▲ 18.4%
2024 · €259,122
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202022202320242025
Operating result€1.2m▲ 876%€192,551-€39,004▼ 79.7%€114,954▲ 195%€201,589▲ 75.4%
Net result€1.1mabove the sector's middle half▲ 1,193%€141,056within the sector's middle half-€35,614within the sector's middle half▼ 74.8%€127,432within the sector's middle half▲ 258%€186,710within the sector's middle half▲ 46.5%
Equity€328,614within the sector's middle half▲ 9.2%€369,670within the sector's middle half-€375,284within the sector's middle half▲ 1.5%€402,716within the sector's middle half▲ 7.3%€439,425within the sector's middle half▲ 9.1%
Total assets€1.8mwithin the sector's middle half▲ 108%€971,448within the sector's middle half-€1.1mwithin the sector's middle half▲ 15.7%€1.3mwithin the sector's middle half▲ 18.0%€1.4mwithin the sector's middle half▲ 9.1%
Debt€1.5m▲ 161%€601,778-€748,966▲ 24.5%€923,438▲ 23.3%€1.0m▲ 9.1%
Working capital€317,089within the sector's middle half▲ 11.2%€321,861within the sector's middle half-€188,447within the sector's middle half▼ 41.5%€259,122within the sector's middle half▲ 37.5%€306,755within the sector's middle half▲ 18.4%
Solvency18.3%below the sector's middle half▼ 16.6pp38.1%within the sector's middle half-33.4%within the sector's middle half▼ 4.7pp30.4%within the sector's middle half▼ 3.0pp30.4%within the sector's middle half=
Current ratio1.22within the sector's middle half▼ 0.301.56within the sector's middle half-1.27within the sector's middle half▼ 0.291.29within the sector's middle half▲ 0.021.31within the sector's middle half▲ 0.02
Return on assets (ROA)63.3%above the sector's middle half▲ 53.1pp14.5%above the sector's middle half-3.2%within the sector's middle half▼ 11.4pp9.6%above the sector's middle half▲ 6.4pp12.9%above the sector's middle half▲ 3.3pp
Staff (FTE)4within the sector's middle half▲ 5.3%4within the sector's middle half-4.1within the sector's middle half▲ 2.5%4.4within the sector's middle half▲ 7.3%6.2within the sector's middle half▲ 40.9%
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
  • 2023 Net result -75% on 2022. This fiscal year ran 15 months, the previous one 21.
Result per fiscal year
Operating resultNet result
€0€500,000€1.0mOperating result 2020: €1.2m€1.2mNet result 2020: €1.1m€1.1mOperating result 2022: €192,551€192,551Net result 2022: €141,056€141,056Operating result 2023: €39,004€39,004Net result 2023: €35,614€35,614Operating result 2024: €114,954€114,954Net result 2024: €127,432€127,432Operating result 2025: €201,589€201,589Net result 2025: €186,710€186,71020202022202320242025€0€100,000€200,000Operating result 2023: €39,004€39,000Net result 2023: €35,614€35,600Operating result 2024: €114,954€115,000Net result 2024: €127,432€127,000Operating result 2025: €201,589€202,000Net result 2025: €186,710€187,000202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 75% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.4m
Fixed assets €145,539 ▼ 15.7%
Current assets €1.3m ▲ 12.8%
Equity and liabilities €1.4m
Equity €439,425 ▲ 9.1%
Debt €1.0m ▲ 9.1%
Debt's share of the balance-sheet total stays at 69.6%.
Key figures and ratios
2025 value · change against 2024
EBITDA
€263,906▲
2024 · €165,574
Cash flow
€249,027▲
2024 · €178,052
Quick ratio
0.90▲
2024 · 0.86
Debt to equity
2.29=
2024 · 2.29
ROE
42.5%▲
2024 · 31.6%
Interest coverage
46.51▲
2024 · 17.23
Debt ≤ 1 year
€994,377▲
2024 · €894,369
Debt > 1 year
€12,869▼
2024 · €29,070
Income taxes
€17,754▲
2024 · €7,813
Staff costs
€258,949▲
2024 · €203,985
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 31,349 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.4% went bankrupt
5.9% stopped otherwise
93% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 31,349 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 59 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.3m€1.4m▲
Fixed assets21/28€172,663€145,539▼
Intangible fixed assets21€29,711€30,239▲
Tangible fixed assets22/27€137,592€109,940▼
Plant, machinery and equipment23€1,961€1,252▼
Furniture and vehicles24€131,619€105,125▼
Other tangible fixed assets26€4,012€3,563▼
Financial fixed assets28€5,360€5,360=
Current assets29/58€1.2m€1.3m▲
Stocks and contracts in progress3€380,000€401,253▲
Stocks30/36€380,000€401,253▲
Amounts receivable within one year40/41€514,902€481,162▼
Trade receivables40€475,521€462,972▼
Other amounts receivable41€39,382€18,191▼
Cash at bank and in hand54/58€258,589€410,981▲
Deferred charges and accrued income490/1-€7,735
Equity and liabilities
Total equity and liabilities10/49€1.3m€1.4m▲
Equity10/15€402,716€439,425▲
Contributions10/11€62,000€62,000=
Capital10€62,000€62,000=
Issued capital100€62,000€62,000=
Reserves13€313,284€313,284=
Non-distributable reserves130/1€6,200€6,200=
Legal reserve130€6,200€6,200=
Tax-exempt reserves132€6,593€6,593=
Distributable reserves133€300,491€300,491=
Profit (loss) carried forward14€27,432€64,141▲
Amounts payable17/49€923,438€1.0m▲
Amounts payable after more than one year17€29,070€12,869▼
Financial debts170/4€29,070€12,869▼
Amounts payable within one year42/48€894,369€994,377▲
Current portion of amounts payable after more than one year42€21,015€16,201▼
Trade debts44€688,682€735,714▲
Suppliers440/4€688,682€735,714▲
Taxes, remuneration and social security45€69,612€77,526▲
Taxes450/3€41,990€54,364▲
Remuneration and social security454/9€27,622€23,163▼
Other amounts payable47/48€115,059€164,936▲
Income statement Code20242025
Non-recurring operating income76A€239-
Remuneration, social security and pensions62€203,985€258,949▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€50,620€62,317▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€7,864€1,234▼
Other operating charges640/8€31,275€7,914▼
Non-recurring operating charges66A€80-
Gross operating margin9900€408,778€532,003▲
Operating profit (loss)9901€114,954€201,589▲
Financial income75/76B€29,902€8,549▼
Recurring financial income75€29,902€8,549▼
Financial charges65/66B€9,611€5,674▼
Recurring financial charges65€9,611€5,674▼
Profit (loss) for the period before taxes9903€135,245€204,464▲
Income taxes67/77€7,813€17,754▲
Profit (loss) for the period9904€127,432€186,710▲
Profit (loss) for the period to be appropriated9905€127,432€186,710▲
Appropriation of the result
Profit (loss) to be appropriated9906€127,432€214,141▲
Profit (loss) brought forward from the previous period14P-€27,432
Profit to be distributed694/7€100,000€150,000▲
Directors or managers695€100,000€150,000▲
Social balance
Average headcount (FTE)90874.46.2▲

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202022202320242025Change
Non-recurring operating income76A-€2,500€13,002€239--
Remuneration, social security and pensions62-€303,641€232,457€203,985€258,949▲ 26.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12,790€28,692€36,985€50,620€62,317▲ 23.1%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€19,005€12,372€7,864€1,234▼ 84.3%
Other operating charges640/8-€12,205€13,070€31,275€7,914▼ 74.7%
Non-recurring operating charges66A-€0-€80--
Gross operating margin9900€1.4m€556,093€333,888€408,778€532,003▲ 30.1%
Operating profit (loss)9901€1.2m€192,551€39,004€114,954€201,589▲ 75.4%
Financial income75/76B-€8,141€19,982€29,902€8,549▼ 71.4%
Recurring financial income75€1,733€8,141€19,982€29,902€8,549▼ 71.4%
Financial charges65/66B-€31,875€15,046€9,611€5,674▼ 41.0%
Recurring financial charges65€25,325€31,875€15,046€9,611€5,674▼ 41.0%
Profit (loss) for the period before taxes9903€1.1m€168,816€43,940€135,245€204,464▲ 51.2%
Income taxes67/77€13,301€27,760€8,326€7,813€17,754▲ 127%
Profit (loss) for the period9904€1.1m€141,056€35,614€127,432€186,710▲ 46.5%
Transfer from tax-exempt reserves789-€19,011€0---
Profit (loss) for the period to be appropriated9905€1.1m€160,066€35,614€127,432€186,710▲ 46.5%
Line20202022202320242025Change
Assets
Total assets20/58€1.8m€971,448€1.1m€1.3m€1.4m▲ 9.1%
Fixed assets21/28€11,524€71,751€236,906€172,663€145,539▼ 15.7%
Intangible fixed assets21€5,157€0-€29,711€30,239▲ 1.8%
Tangible fixed assets22/27€3,798€64,081€227,446€137,592€109,940▼ 20.1%
Plant, machinery and equipment23-€488€0€1,961€1,252▼ 36.1%
Furniture and vehicles24-€63,593€179,096€131,619€105,125▼ 20.1%
Other tangible fixed assets26--€48,351€4,012€3,563▼ 11.2%
Financial fixed assets28€2,570€7,670€9,460€5,360€5,360=
Current assets29/58€1.8m€899,697€887,343€1.2m€1.3m▲ 12.8%
Stocks and contracts in progress3€211,160€198,000€299,616€380,000€401,253▲ 5.6%
Stocks30/36-€198,000€299,616€380,000€401,253▲ 5.6%
Amounts receivable within one year40/41€837,995€346,779€332,567€514,902€481,162▼ 6.6%
Trade receivables40-€342,017€328,092€475,521€462,972▼ 2.6%
Other amounts receivable41-€4,762€4,474€39,382€18,191▼ 53.8%
Current investments50/53€42,345€69,192€69,192---
Cash at bank and in hand54/58€687,868€282,410€183,300€258,589€410,981▲ 58.9%
Deferred charges and accrued income490/1-€3,315€2,668-€7,735-
Equity and liabilities
Total equity and liabilities10/49€1.8m€971,448€1.1m€1.3m€1.4m▲ 9.1%
Equity10/15€328,614€369,670€375,284€402,716€439,425▲ 9.1%
Contributions10/11€62,000€62,000€62,000€62,000€62,000=
Capital10-€62,000€62,000€62,000€62,000=
Issued capital100-€62,000€62,000€62,000€62,000=
Reserves13€266,614€307,670€313,284€313,284€313,284=
Non-distributable reserves130/1-€6,200€6,200€6,200€6,200=
Legal reserve130-€6,200€6,200€6,200€6,200=
Tax-exempt reserves132-€6,593€6,593€6,593€6,593=
Distributable reserves133-€294,876€300,491€300,491€300,491=
Profit (loss) carried forward14-€0€0€27,432€64,141▲ 134%
Amounts payable17/49€1.5m€601,778€748,966€923,438€1.0m▲ 9.1%
Amounts payable after more than one year17€0€23,943€50,070€29,070€12,869▼ 55.7%
Financial debts170/4-€23,943€50,070€29,070€12,869▼ 55.7%
Amounts payable within one year42/48€1.5m€577,836€698,896€894,369€994,377▲ 11.2%
Current portion of amounts payable after more than one year42-€8,821€20,491€21,015€16,201▼ 22.9%
Trade debts44€209,688€422,844€579,321€688,682€735,714▲ 6.8%
Suppliers440/4-€422,844€579,321€688,682€735,714▲ 6.8%
Taxes, remuneration and social security45-€32,775€66,199€69,612€77,526▲ 11.4%
Taxes450/3-€11,932€33,992€41,990€54,364▲ 29.5%
Remuneration and social security454/9-€20,842€32,207€27,622€23,163▼ 16.1%
Other amounts payable47/48-€113,396€32,885€115,059€164,936▲ 43.3%
Line20202022202320242025Change
Profit (loss) for the period9904€1.1m€141,056€35,614€127,432€186,710▲ 46.5%
+ Depreciation and write-downs630€12,790€28,692€36,985€50,620€62,317▲ 23.1%
Operating cash flow (approximation)€1.1m€169,748€72,599€178,052€249,027▲ 39.9%
Investment in fixed assets (approximation)---€202,140€13,623-€35,194▼ 358%
Change in cash---€99,110€75,288€152,393▲ 102%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
05-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
16-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
23-08
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 23 days late
2023
31-12
Financial Weakest financial yearnet €35,614 ▼74.8%
Net result drops to €35,614, the lowest in the series; recovery starts the following year.
25-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 25 days late
2021
19-08
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 19 days late
2020
31-12
Financial Highest result since 2018net €1.1m ▲1,193%
Operating result €1.2m, net result €1.1m, both a record.
28-08
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 28 days late
2019
29-08
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 29 days late
2018
28-08
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 28 days late
2017
21-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 21 days late
2016
29-08
NBB filing Annual accounts filed
fiscal year 2015 · full schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts

We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 1992
seat establishment approximate The establishment unit on the map
Ground area
3,667 m²
Building footprint
1,060 m²
Volume, LiDAR
15,939 m³
2 parcels, Brussels, Wallonia · tallest building 52.2 m, ±16 floors. Linked by address, not a title deed.
143 companies at this address See who is registered here
1 establishment unit
Rue du Développement durable(L) 24, 7900 Leuze-en-Hainaut
NACE 51460
since 19922.059.922.484
2 parcels
Wallonia 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
57019B0061/00M000 Wallonia 2,870 m² 1 · 727 m² -
21308H0298/00G000 Brussels 797 m² 1 · 333 m² 52.2 m · 16 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner

Chain of control

  1. MEDISOLUTIONS 100%
  2. PHARMAMED

Highest known parent: MEDISOLUTIONS. The sources do not say who stands above it.

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 769 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded02-08-1991
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
Contact
E-mail info@pharmamed.be
Phone 068646045
E-invoicing
Reachable via Peppol
Peppol ID 0208:0444844572
Also 9925:BE0444844572
Registered 15-10-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.